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Abstract 
The described method permits the determination  one of the most common metabolite of the 
pyrethroids permethrin, cypermethrin, deltamethrin, λ-cyhalothrin, fenvalerate, phenothrin 
and β-cyfluthrin in human urine: The 3-phenoxybenzoic acid (3-PBA) . After alkaline hydrolysis 
to release the conjugated carboxylic acid metabolite, the analytes were separated from the 
matrix by means of solid-phase extraction using a reversed-phase/strong cation exchange 
column. The components of the eluate were converted to their Hexafluoroisopropane esters 
and extracted in hexane. Separation and quantitative analysis of this pyrethroid metabolite was 
carried out by capillary gas chromatography and mass selective detection. 2-Phenoxybenzoic 
acid served as an internal standard. The detection limits was 0,0038 μg per ml urine. The 
relative standard deviations of the within-series imprecision were always less than 10%. Using 
this method we determined the elimination of 3-PBA in 46 children( 24 autistics,22 controls), 
the average values in urine of each population were 1,48 µg/ml in ASD (Variance 4,94) and 0,63 




 “All the airplane that can land in Chicago along a day, landing all together in the same 
moment”.        
                    
 With this picture Nancy Minshew, researcher in Pittsburgh University, describe the intricate 
network and consequently, the abnormal communication through the different brain parts 
in children affected by Autistic Spectrum Disease. 
Autistic spectrum disease (ASD) are a group of disorders characterized by qualitative 
impairment in social interaction and communication, and restricted repetitive and 
stereotyped patterns of behaviour, interests and activities (Diagnostic and Statistical Manual 
of Mental Disorders, 4th Edition (DSM-IV);[1] International Classification of Diseases-10 (ICD-
10)[2]). 
1.1 Autism 
Autism was first outlined in 1943 by Leo Kanner, an Austrian-US-American Professor of Child 
Psychiatry. He described children with mental retardation and severe social isolation not 
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explained by the developmental level of the children[3]. Kanner referred to Eugen Bleuler by 
naming the syndrome 'infantile autism' based on Bleulers schizophrenia criterion describing 
the loss of social interest in schizophrenia. At the same time, Professor Hans Asperger in 
Vienna, Austria, noticed similar patients with 'autistic psychopathy' and normal intellectual 
abilities[4] Hans Asperger noted that fathers of these children seemed aloof and socially 
isolated. Both, Kanner and Asperger, suspected a biological or even genetic origin of the 
disorder.However, this knowledge was lost during the 1950–1960s, until Michael 
Rutter[5] and Lorna Wing[6] resumed discussion on diagnostic concepts, differential diagnosis 
and aetiology of AD in the 1970s and 1980s. 
These disorders seems increasing in their number in the last years; in fact recent studies 
spokes about 400.000 children only in Italy with an ASD diagnosis, this rapid increasing could 
cause some worries, but for the most of that the merit is a better knowledge and precise 
classification about the clinical picture. 
The most commons features of ASD are divisible in three core: 
 Socializing Difficulty; 
 Monotonous and repetitive game playing in early ages; 
 Low interest on the external environment. 
Are also notified a particular interest on moving things, especially round movements, and a 
low weight in birth age. 
The Autism Spectrum Disease can be divided in three different clinical pictures: 
Autism and Autism at high functionality show impairments in all three areas and an 
abnormal development before age 3 years. With a high cognitivity of the external 
environment thanks to the high functionality, but a still inability in socializing. Common in 
the high functionality phenotype a particular ability in calculation and repetitive pattern 
movements. 
Asperger Syndrome is characterized by qualitative impairment in social interaction and 
restricted repetitive and stereotyped patterns of behaviours, interests and activities with an 
apparently normal language and cognitive development before age 3 years. Interesting is 
also speaking about the predominance of male children affected, and about the character of 
the subject that in the measure of the man-kind mental difference is classifiable to be 
bizarre, naïve, literal in the meaning of communication inducing to think about a leak of 
archness, in fact their language commonly, is polished. The children most of the time shown 
good ability and interest for uncommon hobbies, those could increase the isolation-state of 
the subject, causing possible comorbidity in the adolescence age like Auto-aggressive 
behaviour, schizophrenia, anxiety, obsession… 
PDD-nos (pervasive developmental disorder not otherwise specified) is diagnosed in 
individuals who meet autism criteria, but show a late age of onset, or in individuals who 
show severe and pervasive impairment in one or two of the three core areas with or without 
cognitive or language delay. The central difference lies in an apparently normal development 
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until age 2 years and a clinically significant loss of skills before age 10 years. Owing to the 
rarity of the disorder (15/10 000)[8] systematic studies regarding its aetiology are missing.  
 
The therapy commonly used for the treatment of this large spectrum disorder is an 
association by a Neuro-cognitive and a Pharmacological approach, that should be actuated 
as soon as possible in the child affected by this kind of disorder been it predominantly 
classified as a leak, or preferably known, as a difference, in network and communication 
through the different part of the brain. This differences could be changed or reduced by an 
adequate neuro-cognitive approach therapy in this age (0-6 years), where the neuroplasticity 
and sinapto-genesis are predominantly. Following with a cognitive-behavioural approach in 
the adolescence period eventually coadiuvated by a pharmacological approach, to reduce 
the co-morbidity with other disturb, working for the social adaptation in a sort of alliance 




 Neuro-Imaging (fMRI-BOLD, sMRI, PET) Approach: 
 
Recently, a great deal of attention has been focused on the delineation of neural systems for 
brain-behaviour relationships in autism. At the brain circuit level, most of what we 
understand about autism and its biological abnormalities come from technological advances 
in diagnostic brain imaging with positron emission tomography (PET) and magnetic 
resonance structural (sMRI) and functional (fMRI ) that have had a profound impact on our 
understanding of the neurobiological basis of autism through the study , anatomical and 
functional connectivity of the brain, greatly improving the ability of researcher to examine 
the neural substrates of cognitive processes. 
Biological research results: 
Although many of the cognitive and behavioral features of ASD are thought to arise from 
dysfunction of the central nervous system (CNS), many fields of medicine has documented 
suggesting that in some individuals, ASD arises from systemic, rather than organ-specific 
abnormalities. Specifically in the recent decades, research and clinical studies has been 
implicated with physiological and metabolic systems that transcend specific organ 
dysfunctions, such as immune dysregulation, inflammation, impaired detoxification, 
environmental toxicant exposure, redox regulation/oxidative stress and energy 
generation/mithocondrial systems. 
For each of that we have a large percentage of publication that implicate an association 
between ASD and immune disregulation/inflammation (416 out of 437 publications, 95%), 
oxidative stress(all 115), mitochondrial dysfunctions (145 of 153, 95 %) and toxicant 
exposure (170 of 190,89%).In this context, ASD may arise from, or at least involve , systemic 
physiological abnormalities rather than being a purely CNS disorder, at least in a subset of 
individuals with ASD.[9] 
Research studies in a wide variety of psychiatric disorders, including ASD, have started to 
investigate gene-environment interactions and epigenic factors, rather than fixed genetic 
defects. Other research studies examining the etiology of psychiatric disorders have 
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embraced the study of pathophysiological mechanism that could more directly result in 
cellular dysfuction and the subsequent development of psychiatric disorders have embrace 
the study of pathophysiological mechanism that could more directly result in cellular 
dysfunction and the subsequent development of psychiatric disorders. Like ASD, 
pathophysiological mechanism identified in some psychiatric disorders include immune 
dysregulation, inflammation, impaired detoxification, enviromental toxicant exposures, 
redox regulation/oxidative stress and mitochondrial dysfunctions. Immune dysregulation 
and inflammation has been implicated in several psychiatric disorders. For example, 
neuroinflammation, which generally refers to CNS-specific, chronic glial reactions that may 
not demonstrate typical peripheral evidence of inflammation, has been implicated in several 
psychiatric disorders, including Alzheimer’s disease, schizophrenia, bipolar disorder, and 
depression as well as ASD. Neuroinflammation can damage brain tissue through several 
mechanisms, including plaque formation, abnormal neuron growth, increased tau 
phosphorylation and proinflammatory citokynes release.[9] 
Enviromental toxicant exposure are also very important in the etiology of a wide variety of 
disorders. Toxicants, such as heavy metals, pesticides and chemicals, can damage cell by 
converging on similar biochemical pathways to produce adverse effects, such as increasing 
oxidative stress, depleting glutathione and impairing cellular signaling. Exposures to 
environmental toxicants were been trusted as causes in certain psychiatric disorders, such as 
ADHD, depression and schizophrenia as well as ASD.[9] 
Furthermore, Oxidative stress is defined as damage to cellular tissue caused by free radicals 
such as reactive oxygen species. Oxidative stress is also implicated in a large variety of 
disorders including cardiovascular disease, diabetes and hypertension.  
Oxidative stress has also been reported in some individuals with ASD. In fact of the 51 
clinical and 7 treatment studies in ASD: the 88% of the studies reported abnormal 
biomarkers of oxidative stress ,including alterations in glutathione(16 studies), vitamine E (3 
studies), tetrahydrobiopterin(4 studies) and antioxidant enzyme levels, such as glutathione 
peroxidase, paraoxonase, and superoxide dismutase (11 studies). Eight studies reported 
mutations in antioxidant enzymes or pathways, such as glutathione peroxidase, superoxide 
dismutase, glutathione-S-trasferase, delta aminolevulenic acid dehydratase, 
methilenetetrahidrofolate reductase, catechol-O-metiltasferase and reduced folate carrier. 
Five studies reported a positive correlation between biomarkers of greater oxidative stress 
and the severity of ASD.[9] 
Finally disfuction in mitochondria, distinct cellular organelles that oxidize glucose and fatty 
acids to generate adenosine triphosphate, the energy carrier in most mammalian cells has 
been implicated in several psychiatric disorders including schizophrenia, bipolar disorder, 
depression, dementia as well as ASD. Fifty-three(84%) of these studies reported abnormal 
biomarkers, which could relate to mithochondrial dysfuction. Commonly abnormal 
biomarkers included lactic acid(18 studies), pyruvate(11 studies), carnitine(7 studies) and 
plasma amino acids(4 studies). In addition to energy production, mitochondria are intimately 
involved in programmed cell death (apoptosis), calcium homeostasasis, synaptic plasticity 
and neurotrasmitter release. Two studies reported a positive correlation between 
biomarkers of mitochondrial dysfunction and the severity of ASD.[9] 
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Consequently these three disorders, Autism, Asperger syndrome (AS) and Pervasive 
Developmental Disorder not otherwise specified (PDD-nos) are currently conceptualized by 
most researchers as a set of disorders with different causes. 
 
1.3 About Pyrethroids 
The Pyrethrins were already known in ancient Mesopotamia and in the ancient world with 
the name of “Persian powder” .They are natural organic molecule produced by the flowers 
of pyrethrums (Chrysanthemum cinerariaefolium and C. coccineum). [10]  
 
              
 
Figure-1 Chrysanthemum cinerariaefolium                           Figure-2 Chrysanthemum coccineum 
The pyrethrins (natural pyrethroids), obtained from pyrethrum, are very unstable to light, 
Due to this fact, the use is quite limited. However due to its natural characteristics this 
substance aroused enormous interest in some organic chemists.  
 
Figure-3 Pyrethrum structure 
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In mid-year 1910 came the first study about the Pyrethrins by a team of Rothamsted 
Research scientists, following the elucidation of the structures of pyrethrin I and II by 
Hermann Staudinger and Leopold Ružička, in 1958 it was completed, and with it,  the 
discovery of six active compounds structures: Pyrethrin I, Pyrethrin II, Cinerin I, II Cinerin, 
jasmolin I and II jasmolin[11]. In the following period, various pyrethroids were synthesized 
from pyrethrins. Since that time came to be known as pyrethroids, natural pyrethrins and 
their synthetic derivatives. It has been shown that the centers of photostable pyrethroids 
molecular structure could be replaced by alternative units, producing compounds more 
stable to light, but retaining its insecticidal capacity and continues to be somewhat harmful 
to mammals, calling up these substances as synthetic pyrethroids [ 12]. 
 The classification of such insecticides may be made according to when they were created (4 
series), or by the presence or absence of the cyano group (type I or type II). The first 
generation pyrethroids : Allethrin was constituted only by (a synthetic duplicate of cinerin I), 
the allethrin was first marketed in the year 1949, from this moment start took place an era 
of very complex synthesis, involving 22 chemical reaction[13]. With new developments 
appeared to second generation pyrethroids, more effective than the natural pyrethroids 
since they were photostable and effective for use in agriculture and domestic use. In 1976 it 
was discovered the first photostable synthetic pyrethroid, Fenvalerate, Permethrin 
following, already in 1977. These two types of insecticides are also classified as third 
generation insecticides since their characteristics are listed in stability to sunlight and its low 
volatility. In the 80’s began the fourth generation of pyrethroids, this new step differs from 
previous ones, because they synthesize from cyclopropane, and because the amount 
required  for the production thereof is much lower than those of previous generation. 
Examples of fourth generation pyrethroids are cyfluthrin (1980), flumethrin (1982), and 
fenpropan-fluvalinate (1983), cyhalothrin and bifenthrin (1985) and lastly tefluthrin (1987). 
Regarding the presence or absence of the cyano group, the pyrethroid can be classified as 
type I (absence of the cyano group) and type II (presence of  cyano group). This classification 
is also based on the symptoms presented laboratory animals following exposure to various 
types of pesticides PYRS, since the cyano group influences the mode of action of the 
insecticide. Of type I pyrethroids are part Bifenthrin and Permethrin, as type II may be 
considered to fenpropathrin, λ-cyhalothrin, cypermethrin and deltamethrin [14]. 
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Figure-5 The two classes of 
pyrethroid in according with the 
presence or absence of the cyano 
group (type I or type II) the insecticidal 
effectiveness of these compounds is 
due to their Stereoisomery. Several 
pyrethroids have different isomeric 
forms, thus demonstrating toxicities 










Pyrethroids now constitute the majority of commercial household insecticides. In the 
concentrations used in such products, they may also have insect repellent properties and are 
generally harmless to human beings in low doses but can harm sensitive individuals. 
Metabolism: 
The 3-phenoxybenzoic acid (3-PBA) is the most common metabolite of 10 of 18 pyretroids 
registered in the United States, including permethrin, cypermetrin, deltametrin, 
esfenvalerate[15]. Both type I and type II pyretroids undergo ester hydrolysis which results in 
a cyclopropyl acid and either 3-phenoxybenzyl alcohol (type I) or a cyanohydrin (type II) [16]. 
The aromatic alcohol is further oxidized to 3-PBA while the cyanohydrin is able to 
spontaneously rearrange to the phenoxybenzylaldehyde in aqueous solution and then 
undergo hydroxylation to 3-PBA. 3-PBA is a non-specific urinary metabolite, meaning that it 
is a breakdown product common to most of the pyretroids with the exception of cyfluthrin. 
It is also the most frequently detected urinary metabolite in humans. 3-PBA has been 
detected in urine from the general population in the United States (0.32 µg/L), Germany (2.0 
µg/L reference value), Italy(0.88 µg/L urban and 0.71 µg/L rural) and Japan (0.29 µg/L). 
Levels in occupationally exposed population such as pest control workers tend to be higher 
(6.8 µg/g creatinine)[17][18]. Since 3-PBA it has been used as a marker of pyrethroid. 
In Animal feeding studies using rats, goats, cows and hens, pyrethroid was metabolized 
quickly in the liver. Hydrolysis, hidroxylation, oxidation and conjugation are all involved in 
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the process of metabolism[17][18]. Permethrin is easily hydrolyzed, and the hydrolysis product 
is also easily oxidized in rat’s tissue in vitro. Permethrin is converted to PBAlc (3-
phenoxybenzyl alcohol) and further to PBAcid by mixed function oxidase in rats. Trans-
isomers are more rapidly metabolized by hydrolytic (esterase) pathways while cis-isomers 
are preferentially metabolized by slower oxidative (P450) pathways [19].The trans-isomers of 
permethrin is mainly catalized by the CES1 family and partly by the CES2 family. The cis-
isomers of permethrin, which is metabolized predominantly by P450’s in laboratory 
animals[20], was not detectably metabolized in human liver microsomes in the presence or 
absence of an NADPH regenerating system[21]. Oxidation of PBAlc and PBAld are mainly 
mediated by mixed function oxidase, in addition to ADH (alcohol dehydrogenase) and ALDH 
(Aldhehyde dehydrogenase), which were shown to contribute to the oxidation [Hodson and 
coworker (2002;2003)]. The alcohol generated from permethrin, PBalc is oxidized to PBAld 
(3-phenoxybenzylaldehyde), and the aldehyde is further oxidized to 3- 
PBA. The alcohol and aldehyde moieties of pyrethroids are mainly metabolized by oxidation 
to the corresponding aldehydes and carboxylic acid by ADH and ALDH in mammalian species 
[21]. The terminal phase of pyrethroid metabolism is the formation of glucoronide and glycine 
conjugates. These pathways appear similar between laboratory animals and humans. 
Common metabolites are found in the urine of both laboratory animals and humans [21][23].  
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Table 1. Pyrethroids and Pyrethrins and their corresponding Metabolite. 
 
Excretion of 3-PBA: 
Pyrethroids and its metabolites are excreted primarily in the urine, but also in the feces 
[29],[21]. The 3-PBA excretion was investigated in rats intact and bile duct-cannulated rats. . 
The major biliary metabolites was 3PBA-glucuronide,but we can have glycine conjugates too, 
that it was subsequently deconjugated, readsorbed and undegoes further metabolism, 
principally to the sulfate ester which is excreted in urine[29]. The elimination half-life is about 
8 h reported for 3-PBA among workers exposed to cypermethrin[30] suggest that 88% of the 
metabolite is excreted within the 24 h following exposure. 
Toxicity and health effect: 
Before 1970, there was little information available on the acute toxicity resulting from 
exposure to pirethroid insecticides (natural and synthetic) in mammals [31] Studies published 
in 1970 concluded that there are two syndromes associated with acute exposure to 
pyrethroids in rats[32]. However, pyrethroids have been the subject of some controversy 
about the possible toxic effects over time in humans[33][34].Some studies suggest a 
relationship between exposure to pyrethroids and the appearance of Parkinson's disease . 
 Pyrethroids are not cholinesterase inhibitors such as organophosphates and carbamates but 
act as contact or ingestion of toxic affecting the central and peripheral nervous system of 
insects, even in low doses.[35][36] The activity of pyrethroids is a lipophilic membrane 
environment and consist of sodium channels excite the sodium-potassium pump, present in 
the membranes of nerve cells of insects and mammals interfering in permeability to sodium 
ions, resulting in synaptic repetitive discharges, membrane depolarization and ultimately 
death. The toxic effects are caused mainly by a repetitive induction of nerve activity 
mediated by interaction of  pyrethroid with the membrane sodium channels. The adverse 
effects induced by pyrethroids are a consequence of neuronal hyperexcitability[37]. 
The presence or absence of α-cyano group will be reflected in the duration and effectiveness 
of the insecticide effect on sodium channels. The absence of α-cyano group (Type I 
pyrethroid), such as permethrin results in a shorter end. 
 Pyretroids are lipophilic molecule than they are accumulates in the fat tissues, especially the 
cerebellum tissue (67% of fat).For example the maximum amounts of permethrin in rats 
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tissue of cerebellum, hippocampus, caudate putamen, frontal cortex, hypothalamus, and 
sciatic nerve were about 1.5, 2, 2, 2.7, 4.8, and 7.5 times higher than in plasma, so, 
respectively, indicating an accumulation of pyretroid by nervous tissue itself [38] 
 According to their chemical structure and their biodistribution, pyrethroids can cause: 
-T-syndrome (tremors, sensivity to sensory stimuli, ataxia, convulsions and paralysis) 
-CS-syndrome[39](choreoatheosis, hypersensivity to external stimuli, salivation and, in some 
cases paralysis)[40] 
Usually T-syndrome is caused by pyrethroids non-containing an alpha-cyano group in their 
molecule and CS-syndrome derives by pyrethroid with an alpha-cyano group. Many 
pyrethroids, such as permethrin, exihibit both T and CS characteristics and sometimes this 
two syndromes combine[41]. Pyrethroids interfers with sodium channels and probably with 
calcium-channels (VSSC) and Chloride channel too[42][43], this interactions disrupt the 
function of neurons, and causes spasm on muscles, culminating in paralysis and death .[44] 
It is demonstrated that Pyrethroids can induce several toxic effects also on: 
-Immune system toxicity: even small doses of pyretroids can reduce the ability of immune 
system to respond to foreign proteins. Over 40% of T-lymphocytes and natural killer (NK) 
cells are inhibited by a dose of pyretroids equivalent to 1/100 of the LD50[45]. 
-Lungs: repeated inhalation may cause asthma and pneumonia, burning, numbness, itching, 
erythema and hypersensibility . 
 
-Reproductive system effects: pyrethroids bind to receptors for androgen[46] and to the 
peripheral benzodiazepine receptor (which stimulates production of 
testosterone)[47].Moreover it inhibits the binding of estradiol to the estrogen receptor.[48] 
-Mutagenic effects: an increase in chromosome aberration, chromosome fragments and 
DNA lesions[46] may occur after a pyrethroids exposure. 
-Cancer: According to the World Health Organization pyrethroids increased the frequency of 
lung tumors in female mice, increasing the expression of a gene involved with the 
proliferation of cells in mammary gland[48][49]. The risk of prostate cancer in men with a 
family history of prostate cancer can increase because of Permethrin exposure[50]. 
Mammals can metabolize in a good way pyrethroids, such as permethrin, before they can 
affect the nervous system[41]. For example the lethal dose (LD50) for permethrin is variable, 
ranging from 430 mg/kg body weight to over 4000 mg/kg for rats[45]. 
But 3-PBA, the most important metabolite of pyrethroids deactivation process can also be an 
other possible toxicant, in the beginning, the complete metabolization requires more steps 
than the other two (3-phenoxybenzylalcohol, 3-phenoxybenzylaldehyde); this more 
articulated deactivation process likely leads to a highest ROS formation [51]. So 3-PBA can 
exerts harmful effect, mainly in the hydrophilic part, of the external part of bilayer. It can 
induce carbonyl group formation and this can be explained by the ease where by carboxyl 
group reacts with protein amino group. When metabolites are in the membrane, they can 
interact with lipids forming crosslink and with proteins via amino group bond, modifying the 
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macromolecule dynamics of the bilayer. This means that all the proteins inside the 
membrane, missing their mobility, will not guarantee the proper cell communication. The 3-
PBA is also responsible for highest lipid peroxidation compared with the other two 
metabolites. This effect could be related with a major production of reactive oxygen species, 
as sub-products due to an increase in oxidative intracellular processes necessary to 
metabolize the compound. Moreover, the oxidation of proteins contribute to modify other 
membrane proteins changing the signal within cells[49]. 
 
 1.4 SPE (Solid-liquid-extraction) 
Solid phase extraction (SPE) is a separation process used in order to separate compounds 
which are dissolved and suspended in a liquid mixture from other compounds according to 
their physical and chemical properties. SPE is used by analytical laboratories to concentrate 
and purify samples for analysis and it can be also used to isolate analytes of interest from a 
wide variety of matrices, including urine, blood, water, soil, beverages and animal tissue [50]. 
The affinity of solutes dissolved or suspended in a liquid (mobile phase) for a solid through 
which the example is passed (stationary phase) is used in order to separate a mixture into 
desired and not desired components. The portion that passes through the stationary phase 
can contain desired analytes or undesired impurities. If the portion retained on the 
stationary phase includes the desired analytes they can then be removed from the 
stationary phase for collection in an additional step, in which the stationary phase is rinsed 
in appropriate eluent. The stationary phase consists in a packed syringe-shaped cartridge, a 
96 well plate or a 47- or 90-mm flat disk, each of which can be mounted on its specific type 
of extraction manifold. The manifold allows multiple samples to be processed by holding 
several SPE media in place and allowing for an equal number samples to pass through them 
simultaneously. A typical cartridge SPE manifold can accommodate up to 24 cartridges. Most 
SPE manifolds are equipped with a vacuum port. Application of vacuum speeds up the 
extraction process by pulling the liquid sample through the stationary phase. After that the 
analytes according to different chemical properties and which are usually based on silica that 
has been bonded to a specific functional group (hydrocarbon chains for reversed phase SPE, 
quaternary ammonium or amino groups for anion exchange and sulfonic acid or carboxyl 
groups for cation exchange)[53]. Sodium chloride can be also added to the sample to the 
extraction efficiency [53]. SPE cartridges should not be allowed to dry any point during 
conditioning and sample loading, in order to keep the sorbent ligands active and prevent air 
from trapping in the cartridges. It would be a good practice to transfer the upper layer 
(containing fewer solid) of the aqueous solution first and the lower layer (containing more 
solids) later because there can be a susceptibility to clogging when samples containing 
suspended solids are to be analyzed. Automation usually reduces or eliminates some 
variations due to manual extraction and it also shortens time required for extraction 
process. SPE is normally used for samples that contain matter causing clogging and high back 
pressure and components that cause high background, misleading peaks or poor sensivity. 
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Clean-up, trace concentration or purification, sample matrix to a form compatible with 
chromatographic analyses and concentrates analytes for increased the sensitivity. Moreover 
can remove interferences and protect the analytical column from contaminants. 
 NORMAL PHASE SPE PROCEDURE: 
In a Normal Phase SPE procedure first of all cartridge have to be equilibrated with a non-
polar solvent or slightly polar, in order to wet the surface and penetrate the bonded phase. 
Then the silica surface is wet with water or buffer of a same concentration as the sample 
through the column. The sample is then added to the cartridge. When the sample passes 
through the stationary phase, the analytes in the samples will interact and retain on the 
sorbent while the solvent, salts, and other impurities pass through the cartridge. After that 
buffer is used in order to wash the cartridge and remove impurities. Then, the analyte is 
eluted with a non-polar solvent or a buffer of the appropriate pH. A stationary phase of polar 
functionally bonded silica with short carbons chains frequently makes up the solid phase. 
This stationary phase will adsorb polar molecules which can be collected with a more polar 
solvent [50].   
 REVERSED PHASE SPE 
Analytes based on their polarity are separated with reversed phase SPE. The stationary 
phase of a reversed phase SPE cartridge is derivatized with hydrocarbon chains, which retain 
compounds of mid to low polarity due to the hydrophobic effect. The cartridge can be 
washed with a non-polar solvent, which breaks up the interaction of the analyte and the 
stationary [50]. A stationary phase of silicon with carbon chains in commonly used. Only non-
polar or very weakly polar compounds will adsorb to the surface[50]. 
 ION EXCHANGE SPE 
Analytes based on electrostatic interactions are separated from the analyte of interest and 
the positively charged groups on the stationary phase using ion exchange sorbents. For ion 




Chromatography is an effective method of separation, identification and determination of 
chemical components that finds application in all areas of science. It began to be used in the 
early twentieth century by the Russian botanist Mikhail Tswett. The chromatography name 
comes from the Greek chroma meaning color and graphein which means write. The name 
came as a result of using the technique to separate multiple plant pigments such as 
chlorophyll and xanthophyll. The separate species appear as coloured bands in [51][52] 
column. The use of chromatography increased exponentially in recent years as a result of the 
necessity in separation of compounds contained in complex matrices, by identification 
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comparing to previously existing standards and purification of the compounds, resulting in 
the development of various types of chromatographic techniques (different possible 
combinations between the stationary and mobile phases) [51]. In all chromatographic 
separations, the sample is transported by a mobile phase, which may be a gas, a liquid or a 
supercritical fluid. The mobile phase is forced via the fixed immiscible stationary phase 
column and placed on a solid surface. The two phases are chosen such that the sample 
components are distributed between the mobile and stationary phase to varying degrees. As 
a consequence the components that are strongly retained on the stationary phase move 
very slowly in the mobile phase flow. The opposite happens with components that bind 
weakly to the stationary phase, they move faster. 
 
Figure 7. The image shows schematically how two substances A and B are separated in a column for 
chromatographic elution ( a kind wash through the column by continuous addition of new volumes of solvent ) 
using a liquid mobile phase . 
 
Gas chromatography (GC or GLC) is a commonly used analytic technique in many research 
and industrial laboratories for quality control as well as identification and quantification of 
compounds in a mixture. GC is also a frequently used technique in many environmental and 
forensic laboratories because is allows for the detection of very small quantities. A broad 
variety of samples can be analyzed as long as the compounds are sufficiently thermally 
stable and volatile. A mobile and a stationary phase are required for this technique. The 
mobile phase (carrier gas) is comprised of an inert gas i. e., helium, argon, or nitrogen. The 
stationary phase consist of a packed column where the packing or solid support itself acts as 
stationary phase, or is coated with the liquid stationary phase (a high boiling polymer). Most 
analytical gas chromatographs use capillary column, where the stationary phase coats the 
walls of a small-diameter tube directly (i.e. 0.25µm film in a 0.32 mm tube). The separation 
of compounds is based on the different strengths of the interactions of the compound 
interact with the stationary phase and more time it takes to migrate through the column 
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The factors which influence the separation of the components are:  
Boiling Point:  
The boiling point of a compound is often related to its polarity. The lower the boiling point is, 
the shorter is the retention time because the compound will spent more time in the gas 
phase. The temperature of the column does not have to be above the boiling point because 
every compound has a non-zero vapor pressure at any given temperature, even solids. 
The polarity of the component versus the polarity of stationary phase: 
 If the polarity of the stationary phase and compound are similar, the retention time increase 
because the compound are similar, it’s increase because the compound interact stronger 
with the stationary phase. As a result, polar compounds have long retention times on polar 
stationary phases and shorter retention times on non-polar columns using the same 
temperature. 
Column temperature: 
An excessively high column temperature can result in a very short retention time but also in 
a very poor separation because all the component mainly stays in the gas phase. If the 
compound does not interact with the stationary phase, the retention time will decrease. At 
the same time, the separation quality deteriorates, because the differences in retention 
times becomes not as pronounced anymore. 
Carrier gas flow rate:  
A high flow rate reduces retention times, but a poor separation would be observed as well. 
Like above, the components have very little time to interact with the stationary phase and 
are just being pushed through the column. 
Column length:  
A longer column generally improves the separation. The trade-off is that the retention time 
increases proportionally to the column length and a significant peak broadening will be 
observed as well because of increased longitudinal diffusion inside the column. Amount of 
material injected: Ideally, the peaks in the chromatogram display show a symmetric shape. If 
too much of the sample is injected, the peak shows a significant tailing, which causes a 
poorer separation. Most detectors are relatively sensitive and do not need a lot of material 
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Microsyringes: 
Syringes are used to inject liquid samples through a rubber diaphragm or septum. The 
sample is heated and maintained at a temperature above the boiling point of the least 
volatile substance of the compound to the entry in the column. The amount of sample to be 
analyzed may range from a few tenths of a microliter up to 20 μL . A "splitter" is often 
necessary since it allows to have knowledge only a fraction of the injected sample, the 
remaining sample being eliminated.  
 
Figure-8 The sample ( 1-2 uL) is introduced from above through a syringe(1) arrives in a cylindrical chamber 
called "liner" where  with the effect of the high temperature ( 200-300 °C ) all components evaporate . The  
resulting gaseous mixture is transferred into the  column by the gas flow in transportation. 
Splitless Mode:  path 3 is closed and the entire sample is transferred by the gas in (2) to the column. The path 4 
is the carrier gas out. 
Split Mode: path 3 is open and part of the sample  injected is carrying by the gas in (2) to escape through the 
path 3.  Not the entire sample is transferred to the column. 
 
Detectors in Gas Chromatography: 
 
 Various detectors can be utilized using GC. The characteristics that should provide an ideal 
detector are adequate sensitivity, and typically ranging from 10-8 to 10-15 g solute, good 
sensitivity and reproducibility, linear response to various solutes, temperature of at least 400 
° C , a short response time; does not destroy the sample. But the perfect detector doesn’t 
exist. In many currently available detectors for gas chromatography, one of the most 




Gas-chromatography mass spectrometry (GC/MS) is an analytical method that combines the 
features of gas-liquid chromatography and mass spectrometry to identify different 
substances within a test sample. 
In order, a compound to be analyse by GC/MS it must be sufficiently volatile and thermally 
stable and some of them require a chemical modification (derivatization), prior to analysis, 
to eliminate unwished absorption effects that, would otherwise affect the quality of the data 
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obtained. Carry by the Helium, the molecules are retained and then elute by the column at 
different retention times. In that way mass spectrometer can detect the ionized molecules 
separately. The samples eluting from the column in the gaseous state, are bombarded and 
fragmented by an electron source, at this stage the chemical bonds of the sample molecules 
are broken down and converted into molecular ions , radical and molecules non-ionized 
which will later be separated from the difference between mass / charge (Ratio). The 
detector determines the load mass molecular weight in relation to the ions produced in the 
sample (m/z), the output is amplified to boost the signal. The signal is send to a computer 
that record all the data produced, converts the electrical impulses into visual displays and 




Figure-8 General scheme of a GC-MS 
The mass analyzer separates the ionized species according to the ratio (m / z). This 
separation is achieved through the use of magnetic or electric fields sectors. There are a 
large number of ion separation methods, but the most common are the ion trap and 
Quadrupole. In this work we used the method ion trap.  
 
Quadrupole Mass Filter 
 
The quadrupole analyzer consists of four parallel metal electrodes arranged in two opposite 
pairs. A direct current (DC) and Alternated current (AC) are applied to each of the ion pairs. 
The use of this combination changes the central trajectory of ions. With the change of the 
potential, only ions with a given ratio m/z will pass through the center of the quadrupole, 
while others are diverted from the central trajectory. In a particular field, the ions rightly 
(m/z) set can pass through the quadrupole oscillating following the route, being called as 
resonant ions, which are those that reach the detector. All non-resonant ions are stopped by 
quadrupole. If the objective is to obtain a spectrum with all the ratios (m / z), the potential 
of the direct current and the amplitude of the alternating current are increased and all ions 
become sequentially resonant thus reaching the detector. The quadrupole analyzers are 
characterized by easy handling, its robustness and Hit ratios (m / z) values up to 4000 [56][57]. 
The ion trap is formed by a central electrode (annular shape), and two terminal electrodes, 
and in the center of the ion trap ions are captured. For greater effectiveness ions must be 
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located right in the center, an RF potential is being applied to the central electrode, causing 
ions in a stable trajectory. There are two types of ion trap: three-dimensional quadrupole 
(dynamic capture) and ion cyclotron resonance (still capture). Both work accumulating ions 
inside, through the manipulation of alternating current and radio frequency simultaneously. 
The capture allows a controlled ions release, which permit their separation and control with 




The ion trap has function and look very similar to the quadrupole, and this is sometimes 
considered a variant of this , however , it is potentially much more versatile and has 
undoubtedly a greater potential for development. Once it had a bad reputation because of 
the very first versions provided inferior results compared to quadrupoles. These results were 
often dependent on the concentration; samples rather concentrated usually produced 
several peaks with mass equal to     [ ion + 1 ] , making the spectrum unusable for research 
on commercial archives . Today, the problems have been overcome and the ion trap was 
found to be more sensitive than quadrupole and able to perform analysis tandem without 
use of further experimentation. 
The designation "ion trap" is considered appropriate because unlike the quadrupole which 
acts only as a mass filter, the spectrometer under examination can trap ions for a period of 
time relatively long, with important consequences. 
This apparatus consists, generally, of three electrodes: a ring electrode with a surface 
shaped as a loop with an inner surface hyperbolic, and two cap-shaped electrodes at the two 
ends (Figures 9). 
The ring electrode works with a sinusoidal radiofrequency field (RF), while the electrodes in 
the cap operate in one of the following three ways: A Potential mass, by means of a DC 
voltage, or AC. 
The mathematics that describes the motion of the ions within the trap is provided by the 
equation of Mathieu. The great advantage of the ion trap is that by controlling the three 
parameters of the RF voltages, AC and DC, you can very easily conduct a variety of 
experiments (for details, see March and Hughes 1989)[53][54]. 
There are three basic methods by which the ion trap can work. First, when the trap is 
operated with a constant voltage Rf and no DC bias between the electrodes in the cap and 
the ring, can expect trapped all ions above a certain threshold value of the ratio m / z. 
Increasing the tension Rf, the threshold value m / z is incremented in a controlled manner 
and the ions expelled in sequence and revealed. The result is the classic mass spectrum and 
this procedure is called mode to "mass-selective instability". The maximum potential Rf 
which can be applied between the electrodes limits the upper extreme of the range of mass 
for this mode. The ions of mass over this upper limit are removed after the voltage Rf is reset 
to zero. 
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The second mode operation using a DC voltage between the caps; the overall result is that 
the ions exist for both a threshold value m/z less, both a higher value. The experimental 
potential of this mode of operation are huge and most of the transactions with ion trap 
using this mode. It is possible to select even a single mass ion. Control selective ion (SIM) is 
an important application of this mode of use. There is no practical limit to the number of ion 
masses that can be selected. 
The third mode of operation is similar to the second, with the addition of an auxiliary 
oscillating field between the electrodes to the cap, so as to increase selectively the kinetic 
energy of an ion in particular. With an auxiliary field of small amplitude ions selected get 
kinetic energy slowly and, during this period, generally undergo collisions that produce 
fragmentation; the result can be an efficient MS-MS close to 100%. If you consider the 
intrinsic sensitivity of the ion trap MS-MS tandem jointly efficiency close to 100%, the use of 
the ion trap experiments tandem mass far exceeds the so-called triple quad. 
Detector  
In most detectors ions are detected after the collision with the surface, resulting in the 
emission of electrons, photons and other ions that can be measured by load detectors and 
radiation. Examples of some detectors are Faraday cup, electron multiplier, ion cyclotron 
resonance, or a multichannel plate (MCP).  
 
1.7 Derivatization  
The derivatization is a fundamental step for the analysis of samples to GC, especially for 
compounds that are poorly volatile or, to eliminate undesirable absorption effects that could 
affect the quality of data obtained. In particular, in this analysis we used a process that aims 
to form derivatives of carboxylic acids with good chromatographic properties using an 
esterification on 3-PBA carboxylic group catalized by an immide. 
 
The procedure is based on two reagents N,N diisopropylcarbodiimide  (DIC) and 1,1,1,3,3,3-















2. Material and methods 
The experimental part of this study includes different phases: 
1. Adaptation and Develop a method to extract the compound of our interest (SPE). 
2. Optimisation of derivatization procedure. 
3. Quantification of 3-PBA level with GC-MS. 
The Work started with a bibliographic research to adapt the method at our analisys. After 
that, was identified the ions ratios m/z and the retention time used to identification the 
compound in the samples. These were followed by the determination of the calibration 
curve realized in according with the bibliographic references, to build a measure scale to 
quantify the amount of the 3-PBA in the samples. 
2.1 Reagents 
Always in this work was used deionized water (18.2 МΩ/cm) product by Elix apparatus 
(Millipore, Molsheim, France). The pyrethroid metabolite selected was the 3-
Phenoxybenzoic-acid (3-PBA) assay 98%, the 2-phenoxybenzoic acid (2-PBA) assay 98% was 
used how internal standard, both compound comes from Sigma Aldrich, Madrid®. 
Derivatization agents: 1,1,1,3,3,3 - Hexafluoroisopropanol (HFIP) assay 99%, N,N 
diisopropilcarbodiimmide (DIC) assay 99%, both from Sigma Aldrich. 
Solvents used in SPE were: Chloride Acid (HCl) assay 37% from Carla Erba Reagents. Rodano 
Italy; Etil acetate (EtOAc) assay ›99,5% from Sigma Aldrich, France; Ammonium Hydroxide 
(NH4OH); methanol (CH3OH) from Valente Ribeiro, Belas Portugal e Sodium Hydrogen 
Carbonate(NaHCO3) assay 99,7% product by Riedel-Haen. Other substances were used in this 
work: Acetonitrile(ACN) by Merck, Darmstadt Germany; Potassium Hydroxide (KOH) assay 
87,5 % by José M. Vaz Pereira, Lisboa Portugal 99,7% product by Riedel-Haen and n-hexane 
by Sigma Aldrich, Germany. 
The SPE cartridge used in our optimized extraction method was Oasis Strata-XC. It’s a 
stationary phase with area of 800 m2/g commonly used for biological matrix containing 
bases of Pka 2-10, so weak bases. It’s a mixed-mode, reversed-phase/strong cation 
exchange, water-wettable polymer. It’s formed by a silica base where it was bound a long-
carbon chain (Hydrophobic group) and an alkyl or aromatic sulfonic acid (Strong cation 














The GC analysis were performed on a Thermo Trace Ultra equipment coupled to the 
detector mass Thermo Polaris working in electron impact mode (EI) at 70 eV, being 
connected to an acquisition system and the integration of Xcalibur data. 
 
   
Figure-10  Gas Chromatography Equipment Trace GC Ultra (1) with detection by tandem mass 
spectrometer ( MS / MS9 with ion- trap MS Thermo Polaris Q ( 2) coupled to the autosampler AS - I 
3000 [57][58]. 
 
2.3 Collection and storage of samples 
 
The urine collection was from the morning (the families brought them to the hospital in 
occasion of blood sampling). An agent took them to the laboratory where the urines were 
centrifuged at 2500 rmp for 10 min. Subsequently were eliminated any precipitate and the 
supernatant was aliquoted and frozen at -80°C . 
 
 
2.4 Analytical Method 
The analysis in urine cannot be performed without a prior sample preparation. On one hand, 
the urine is a complex matrix , and on the other, the metabolite was found in very low 
concentrations to analytical techniques commonly used. For that, it was necessary to extract 
the compound from the medium in which they are, in this case urine, concentrating them 
and removing other compounds that may interfere with the analysis. 
The recommended methods for the extraction and concentration of pyrethroids in urine are 
the solid phase extraction (SPE)[59][60] and liquid-liquid extraction (LLE)[58][53] . 
 
 
2.4.1 Deconjugation of metabolites 
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It was added 1 ml of potassium hydroxide to the samples (V= 5 ml, ≈1 mL urine and water ≈4 








2.4.2  Solid Phase Extraction 
 
In the solid phase extraction of metabolites 3- PBA and internal standard, 2- PBA, the 
procedure consists of three phases: conditioning, the sample passage, washing and elution.  
On the conditioning phase were used 5 mL of ethyl acetate (EtOAc), 5 mL of methanol 
(MeOH), 5 ml deionized water and 5 ml 1N HCl. 
After conditioning the sample was passed through the cartridge without letting air. After in 
the washing phase were added 5 ml of 0.1N ( HCl ) hydrochloric acid, 5 mL of ammonium 
hydroxide (NH4OH), 5mL MeOH and 5mL EtOAc. Subsequently was left the vacuum pump on, 
for about 1 hour to ensure the drying of all the cartridges. Finally, extraction was performed 
with 5 mL of 5 % MeOH in EtOAc [56] (Figure 12). 
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Derivatization is a critical step for determination of pyrethroid metabolites in urine. After the 
addition of the derivatizing reagent HFIP and DIC , derivatives of carboxylic acids are formed 
with good chromatographic properties which allow easily be detected in GC-MS (increased 
sensitivity), while the interfering substances are eliminated[59]. It was did adding 20 µL and 
30 µL of DIC and HFIP at the eluate obtained from the SPE , followed by a vortex mixing for 
10 minutes. 
 
2.4.4 Liquid Liquid Extraction 
 
In the final phase of the procedure was made a liquid-liquid extraction (LLE) with the goal to 
obtain a pure non-polar phase of metabolites , which also has the function of neutralizing 
the excess of derivatizing reagent [59]. Subsequently It was added 1 mL of Natrium 
hydrogencarbonate in the same vial (150 µL of n-hexane and 50 µL of derivatizing reagent), 
followed by a vortex mixing during 10 minutes. Using a micropipette were withdrawn 50mL 
of supernatant (n-hexane) where the metabolites were concentrated,  this quantity was 
transferred in an "insert" placed in a vial. The step is repeated adding a second time other 
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2.4.5 Chromatography  
 
The table 2 show the GC-MS used parameters. 
 
Table 2- The Table summarize the most relevant data on the separation and detection of pyrethroid 
metabolites in urine by GC-MS. In this table are specified type and size of the column, the carrier gas 
and the detector used, the volume injected , the temperatures of the oven, injector , and detector. 
 
Column Type ZLB-XLB 
Column Measure 30mm x 0.25 mm (internal 
diameter) Phenomenex 
Column Program 40-260°C (15°C/min) 
Temperature Liner 250°C 
Carrier Gas Helium; 1,3 mL/min 
Volume Injected  1µL 
Detector Electron Impact, Polaris Q , MS. 
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3. Results and Discussion 
3.1 Population characterization 
 
In this study were analyze urine’s samples came from 46 children of ages between 5 and 12 
years. This population including 24 autistic children with different levels of CARS (Childhood 
Autism Rating Scale) and different sex (20 male and 4 female); compared with 12 controls ( 6 






Figure 13- In this Pie chart is represented the population of children studied divided by gender, 
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3.2 GC-MS analysis 
 
Initially the analysis is operated in total ion scan mode ("Full scan") m/z, [50-650], a 
qualitative analysis performed by GC-MS used to identify the spectrum of our compound in 
interest(3-PBA) and the internal standard (2-PBA). 
 
The molecules of 2-PBA and the 3-PBA are chemically very similar and so the ions selected 
for the identification of metabolites 2-PBA (Fig-14) and the 3-PBA (Fig-15) are also related. 
The molecular ion 364 is common to both, and is also the most abundant ion in the 3-PBA 
compound. The identification of 3-PBA  related to the 2-PBA becomes more precise with the 








Figure 15-Mass fragmentation spectrum for 3-PBA 
 
Subsequently the identification of the mass fragmentation spectrum and the retention time 
of our compounds, the spectrometer is set in selective ion monitoring mode (SIM) method 
really useful for quantitative analysis with different concentrations of analytes, so the 
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Figure 16- Chromatogram showing at Rt 10.37 min: the 2-PBA peak and at Rt 12.05 min: 3- PBA. 
  
Here the relative intensities of the detected ions are compared with the calibration curve. 
Technical parameters such as injection conditions, flow and temperature gradients were 
continuously monitored in order to obtain a better resolution of the chromatographic peaks.  
 
 
3.3 Calibration curve 
 
This step aims to see the linearity of the method used and also permitted us to give an 
appropriate valor at the Peaks Areas comes from the samples data analysis. The linear direct 
calibration is performed with the compounds 2- PBA and 3- PBA. The 2-PBA has internal 
standard function, the concentration chosen was: 50 µg / L, for a quantity of 200 µL in every 
sample contamination. 
The concentrations chosen for the direct calibration linear with 3-PBA were: 0.1 ; 0.2; 0.5; 




Figure 17- Direct Calibration Curve. 
y = 3E+06x + 3E+06 
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3.4 Calibration curve in matrix 
 
After the direct calibration curve, a calibration curve was made “in matrix” consisting in a 
contamination in the same sample composition, in this case urine. A calibration curve was 
carried out with 6 points: 0.1 ; 0.2; 0.5; 0.8; 1; 2 µg /mL. 




Figure 18- Calibration curve in matrix. 
 
It was observed a Peaks Area variation in the internal standard. To validate our results, was 
built a linear recovery using the ratio between the peak areas of the 3 -PBA /2-PBA and then 
compared with the data from urine samples. 
 
 
y = 3E+06x - 341280 
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Figure 19- Recta Ratios 3-pba/2pba 
 
 
The accuracy of the methods developed was assessed by repeatability of parameters for a 
number of N successive injections, under the same operating conditions, with the calculation 
of Relative Deviation Standard (RSD) expressed as a percentage defined by the following 
expression (Equation 1) : 
 
𝑅𝑆𝐷% =  2[1 - 0,5 log(C)] 
 
Equation 1- (Horwitz Eq.) 
 
During this work we used whenever the average of at least three injections for quantifying a 
metabolite, eliminating the amount corresponding to one injection when the RSD was 
greater than 10 %. 
 
The Limit Of Detection (LOD ) of the chromatographic method was calculated from the 






              (2) 
 
 
where sn is the signal / noise corresponding to the concentration chosen in the calibration 
line.  
 




y = 1,699x + 0,353 
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The Limit Of Quantification ( LOQ) in the chromatographic method were calculated from the 






            (3) 
    
 
where sn is the signal / noise corresponding to the concentration chosen in the calibration 
curve. 
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3.5 Values of 3-PBA in studied population 
 
After calculating the values of LOD and LOQ achieving 0.0038 µg / ml and 0.00127 µg / ml 
respectively  the comparison with the data obtained were performed. 6 samples (3 Autistic 
and 3 controls) corresponding to 13.04% of our samples had a concentration of 3- PBA in 
urine < LOD; 11 (5 and 6 Autistic Controls) LOD <[ 3 - PBA ]< 0.5µg /ml corresponding to 
23.91 %; the 19.56 % 10 ( 2 Autistic and 8 controls ) had values including 0.5µg/ml <[ 3 - PBA 
]< 1 µg / ml; the 36.95 % 17 (12 Autistic and 5 controls ) had values of 1 µg /ml <[ 3 - PBA ]< 3 





Figure 20- The picture show the population of samples divided through Autistic and Controls in front 
of their [3-PBA] in urine. We can notice an important decrease in the number of controls along the 
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Picture 21- Here is summarize the difference through the two populations (ASD/CTRL) through their 
average [3-PBA]µg/ml concentrations in urine.  
 
 
An F-Test Two-Sample for Variances was performed in Excel to the values of the samples (Table 3) 
 
Table-3  F-Test Two-Sample for Variances  
 
F-Test Two-Sample for Variances 
   Variable 1 Variable 2 
Mean 1,4822625 0,628918182 
Variance 4,946751486 0,221566995 
Observations 24 22 
df 23 21 
F 22,32621103 
 P(F<=f) one-tail 4,2733E-10 
 F Critical one-tail 2,063280363   
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A t-Test: Two-Sample Assuming Unequal Variances was executed to understand if controls 
and autistic have different average values of 3-PBA. (Table 4) 
 
 
Table 4- t- Test: Two-Sample Assuming Unequal Variances 
 
t- Test: Two-Sample Assuming Unequal Variances 
  Variable 1 Variable 2 
Mean 1,4822625 0,628918182 
Variance 4,946751486 0,221566995 
Observations 24 22 
Hypothesized Mean Difference 0 
 df 25 
 t Stat 1,835315137 
 P(T<=t) one-tail 0,039192008 
 t Critical one-tail 1,708140761 
 P(T<=t) two-tail 0,078384016 




The derivatized 3-PBA compound achieved linearity between the concentration and the area 
of the peak.  
The levels of 3-PBA in 36 urine samples were achieved using the matrix calibration curve. 
Having thus found a statistical difference between the variances in the two populations and 
the majority report confirmed by the one-tail t-Test, we can confirm an higher average 
concentration of 3-PBA in the urine of autistic children compared to controls. 
 
   Future Work 
In consequence of this results, we should encourage a persistence in the study of this 
correlation on a more extensive population, involving more parameters to better classify the 
phenomenon, like: the place of birth, residence, the diet habits, the withdrawal period 
(Winter / Summer) and any anthelmintic treatments. 
In fact, most of these products are insecticides, pesticides and shampoos for pets, skin 
treatments, head lice and mosquito repellents. All products commonly used in the houses 
where the children playing habits, the shorter height, and the incomplete metabolic 
development, especially in the early ages may have a role in the exposition increasing, and 
the consequently toxicant actions of this compounds.  
For that reason it is our duty to know more in depth the toxicity mechanisms about this 
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